These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21645251)

  • 1. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
    Nalesnik MA; Woodle ES; Dimaio JM; Vasudev B; Teperman LW; Covington S; Taranto S; Gockerman JP; Shapiro R; Sharma V; Swinnen LJ; Yoshida A; Ison MG
    Am J Transplant; 2011 Jun; 11(6):1140-7. PubMed ID: 21645251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.
    Green M; Covington S; Taranto S; Wolfe C; Bell W; Biggins SW; Conti D; DeStefano GD; Dominguez E; Ennis D; Gross T; Klassen-Fischer M; Kotton C; LaPointe-Rudow D; Law Y; Ludrosky K; Menegus M; Morris MI; Nalesnik MA; Pavlakis M; Pruett T; Sifri C; Kaul D
    Transplantation; 2015 Feb; 99(2):282-7. PubMed ID: 25594557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor transmitted malignancies.
    Buell JF; Beebe TM; Trofe J; Gross TG; Alloway RR; Hanaway MJ; Woodle ES
    Ann Transplant; 2004; 9(1):53-6. PubMed ID: 15478892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on donor-derived disease transmission in organ transplantation.
    Ison MG; Nalesnik MA
    Am J Transplant; 2011 Jun; 11(6):1123-30. PubMed ID: 21443676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee.
    Ison MG; Hager J; Blumberg E; Burdick J; Carney K; Cutler J; Dimaio JM; Hasz R; Kuehnert MJ; Ortiz-Rios E; Teperman L; Nalesnik M
    Am J Transplant; 2009 Aug; 9(8):1929-35. PubMed ID: 19538493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee.
    Penumarthi LR; La Hoz RM; Wolfe CR; Jackson BR; Mehta AK; Malinis M; Danziger-Isakov L; Strasfeld L; Florescu DF; Vece G; Basavaraju SV; Michaels MG
    Am J Transplant; 2021 May; 21(5):1911-1923. PubMed ID: 33290629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ transplantation from donors (cadaveric or living) with a history of malignancy: review of the literature.
    Zhang S; Yuan J; Li W; Ye Q
    Transplant Rev (Orlando); 2014 Oct; 28(4):169-75. PubMed ID: 25135838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.
    Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
    Transplantation; 2007 Jul; 84(2):272-4. PubMed ID: 17667822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.
    Birkeland SA; Storm HH
    Transplantation; 2002 Nov; 74(10):1409-13. PubMed ID: 12451241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee.
    Kusne S; Taranto S; Covington S; Kaul DR; Blumberg EA; Wolfe C; Green M
    Am J Transplant; 2016 Dec; 16(12):3562-3567. PubMed ID: 27376472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Donation From Brain-dead Organ Donors With Central Nervous System Tumors: Analysis of Transplantation Outcomes in Korea.
    Lee MS; Cho WH; Ha J; Yu ES; Jeong YS; Oh JS; Lee JR; Lee JM
    Transplantation; 2020 Mar; 104(3):460-466. PubMed ID: 31596740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.
    Theodoropoulos NM; La Hoz RM; Wolfe C; Vece G; Bag R; Berry GJ; Bucio J; Danziger-Isakov L; Florescu DF; Goldberg D; Ho CS; Lilly K; Malinis M; Mehta AK; Nalesnik MA; Sawyer R; Strasfeld L; Wood RP; Michaels MG
    Transpl Infect Dis; 2021 Feb; 23(1):e13458. PubMed ID: 32894634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatrics and donor-derived disease transmission: The US OPTN experience.
    Green M; Covington S; Taranto S; Michaels MG; Wolfe C; Kaul DR
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29341396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry.
    Pavlakis M; Michaels MG; Tlusty S; Turgeon N; Vece G; Wolfe C; Wood RP; Nalesnik MA
    Clin Transplant; 2019 Jul; 33(7):e13597. PubMed ID: 31104323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid organ transplant donors with central nervous system infection.
    Kaul DR; Covington S; Taranto S; Green M; Lyon GM; Kusne S; Miller RA; Blumberg EA
    Transplantation; 2014 Sep; 98(6):666-70. PubMed ID: 24914569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.
    Malinis M; La Hoz RM; Vece G; Annambhotla P; Aslam S; Basavaraju SV; Bucio J; Danziger-Isakov L; Florescu DF; Jones JM; Rana M; Wolfe CR; Michaels MG
    Transpl Infect Dis; 2022 Apr; 24(2):e13800. PubMed ID: 35064737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of donor-derived disease: A report of the disease transmission advisory committee.
    Kaul DR; Vece G; Blumberg E; La Hoz RM; Ison MG; Green M; Pruett T; Nalesnik MA; Tlusty SM; Wilk AR; Wolfe CR; Michaels MG
    Am J Transplant; 2021 Feb; 21(2):689-702. PubMed ID: 32627325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direction of the Organ Procurement and Transplantation Network and United Network for Organ Sharing regarding the oversight of live donor transplantation and solicitation for organs.
    Delmonico FL; Graham WK
    Am J Transplant; 2006 Jan; 6(1):37-40. PubMed ID: 16433754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.
    Hays R; Gordon EJ; Ison MG; LaPointe Rudow D
    Am J Transplant; 2019 Dec; 19(12):3233-3239. PubMed ID: 31338956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.